Literature DB >> 1674160

Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens.

N M White1, M G Packard, N Hiroi.   

Abstract

The conditioned place preference technique was used to assess the affective properties of the direct dopamine D1 agonist, SKF38393, and the direct D2 agonist, LY171555 (quinpirole). A three compartment apparatus was used: the animals' pre-experimental preference for the two choice compartments was equal and, within each experimental group, half the rats received drug pairings in each choice compartment. Intraperitoneal injections of SKF38393 produced conditioned place aversions at all doses tested (1.0-4.0 mg/kg); LY171555 produced weak conditioned place preferences at 1.0 and 2.0 mg/kg, but no reliable effect at 4.0 mg/kg. Bilateral intra-accumbens microinjections of SKF38393 produced strong preferences at all doses tested (0.5-2.0 micrograms/side); LY171555 produced strong preferences at two doses (0.5 and 1.0 micrograms/side) and no effect at a third dose (2.0 micrograms/side). These results suggest that activation of either D1 or D2 receptors in the nucleus accumbens can produce reward, and that D1 receptors (and possibly also D2 receptors) located elsewhere in the brain or in the periphery may mediate aversive effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674160     DOI: 10.1007/bf02244216

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens.

Authors:  J C Stoof; P F Verheijden
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

3.  Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions.

Authors:  K E Asin; W E Montana
Journal:  Pharmacol Biochem Behav       Date:  1989-04       Impact factor: 3.533

4.  Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.

Authors:  M S Starr; B S Starr
Journal:  Pharmacol Biochem Behav       Date:  1989-05       Impact factor: 3.533

5.  Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation.

Authors:  S Kurumiya; S Nakajima
Journal:  Brain Res       Date:  1988-05-10       Impact factor: 3.252

Review 6.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

7.  Opposite motivational effects of endogenous opioids in brain and periphery.

Authors:  A Bechara; D van der Kooy
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

8.  Amphetamine-induced taste aversion demonstrated with operant behaviour.

Authors:  I P Stolerman; G D D'Mello
Journal:  Pharmacol Biochem Behav       Date:  1978-02       Impact factor: 3.533

9.  Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions.

Authors:  D van der Kooy; N R Swerdlow; G F Koob
Journal:  Brain Res       Date:  1983-01-17       Impact factor: 3.252

10.  Dopamine and preparatory behavior: II. A neurochemical analysis.

Authors:  J R Blackburn; A G Phillips; A Jakubovic; H C Fibiger
Journal:  Behav Neurosci       Date:  1989-02       Impact factor: 1.912

View more
  30 in total

Review 1.  Hypocretin/orexin involvement in reward and reinforcement.

Authors:  Rodrigo A España
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

2.  Spatially selective reward site responses in tonically active neurons of the nucleus accumbens in behaving rats.

Authors:  A B Mulder; R Shibata; O Trullier; S I Wiener
Journal:  Exp Brain Res       Date:  2005-01-15       Impact factor: 1.972

3.  Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.

Authors:  Rajeev I Desai; John L Neumeyer; Carol A Paronis; Phong Nguyen; Jack Bergman
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

Review 4.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

5.  Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat.

Authors:  T Kling-Petersen; E Ljung; L Wollter; K Svensson
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus.

Authors:  S Cabib; S Puglisi-Allegra; C Genua; H Simon; M Le Moal; P V Piazza
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 7.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

8.  Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Authors:  Elena H Chartoff; Matthew F Barhight; Steve D Mague; Allison M Sawyer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

9.  Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.

Authors:  L Singh; R J Oles; M J Field; P Atwal; G N Woodruff; J C Hunter
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine.

Authors:  Angela E McLelland; Mathew T Martin-Iverson; Richard J Beninger
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.